Wilmington, Delaware, United States, July 17, 2023 (GLOBE NEWSWIRE) -- The global antibody production market is projected to flourish at a CAGR of 7.8% from 2021 to 2031. As per the report published by TMR, a valuation of US$ 30.7 billion is anticipated for the market in 2031. In 2022, the market for antibody production was valued at US$ 15.6 billion
Increasing use of antibodies in the development of therapeutic drugs, including monoclonal antibody-based therapies for cancer, autoimmune diseases, and infectious diseases, and increasing demand for antibody-based therapeutics is likely to drive the antibody production market.
Download Sample Copy with Graphs & List of Figures@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4560
“Connect with our team of research specialists and unlock the optimal solution for driving your business growth”
The increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and infectious diseases is driving the demand for antibody-based therapeutics. Growing emphasis on personalized medicines and increased demand for targeted therapies also drive the antibody production market.
Growing investments in biotechnology research and healthcare infrastructure across various regions are driving the antibody production market. Government initiatives, private investments, and collaborations with academic institutions are fostering the growth of the biotechnology sector and supporting the development and production of antibodies. Increasing technological innovations and advancement in biotechnology, increasing application of antibodies in various diagnostics applications such as point-of-care testing, and molecular diagnostics, driving the growth of the antibody production market.
Key Takeaways from the Market Report
- As of 2023, the antibody production market is forecast to reach US$ 16.8 billion
- By antibody type, the monoclonal antibodies segment is rising significantly due to the increasing application in diagnostics and treatment of various diseases
- Based on the process, the downstream processing segment is expected to account for a significant market share
- By end-user, the pharmaceutical & biotechnology company segment is expected to generate high revenue during the forecast period.
Get Customization on this Report for Specific Research Solutions at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4560
Antibody Production Market: Prominent Drivers and Trends
- The increasing demand for accurate and sensitive diagnostic tests for various diseases, such as infectious diseases and cancer, is creating opportunities for antibody production market growth.
- Increased government regulation and advancement in immunotherapy, personalized medicines demand for antibody production increases.
- Manufacturers are focusing on research & development activities and developing new technology and innovative products to cater to different customer requirements.
Antibody Production Market- Regional Analysis
- North America is expected to hold a significant market share of the antibody production market owing to the presence of a well-established biotechnology and pharmaceutical industry, and strong research and development infrastructure. The increasing prevalence of chronic diseases favorable government initiatives, and increased investments in research drive the demand for antibody production in the region. The presence of key players, academic institutions, and research organizations contributes to the growth of the market in North America.
- The Asia Pacific region is witnessing rapid growth in the antibody production market due to the rising prevalence of chronic diseases, increasing investments in healthcare infrastructure, and the presence of a large population base contributing to the demand for antibody production. The increasing collaborations between international pharmaceutical companies and local manufacturers, along with government initiatives to promote biotechnology and innovation, fuel market growth in the Asia Pacific.
Competitive Landscape
Transparency Market Research has profiled the following players in its global antibody production market report:
- Danaher Corporation
- Merck KGaA
- Sartorius
- Thermo Fisher Scientific Inc.
- Eppendorf AG
- INTEGRA Biosciences AG
- Genetix Biotech Asia Pvt Ltd.
- Solaris Biotech
- Grifols
- F. Hoffmann-La Roche AG
- FiberCell Systems Inc.
Thermo Fisher Scientific is a major player in the antibody production market. In recent years, the company has focused on expanding its antibody portfolio through strategic acquisitions. For instance, in 2020, Thermo Fisher Scientific acquired Phitonex, Inc., a company specializing in the development of fluorescence-based reagents, including antibodies. This acquisition aimed to enhance Thermo Fisher Scientific's capabilities in flow cytometry and antibody-based applications.
Merck KGaA has been actively involved in the development and manufacturing of antibodies. In recent years, the company has emphasized collaborations and partnerships to enhance its antibody production capabilities. In 2020, Merck KGaA announced a collaboration with BeiGene, Ltd. to develop and manufacture investigational antibodies for cancer treatment. This collaboration aimed to leverage Merck KGaA's expertise in antibody manufacturing to support BeiGene's innovative cancer therapies.
Accelerate Your Growth. Get Your Copy of this Premium Research Report Now!
Antibody Production Market – Segmentation
Antibody Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Antibody Types
Process
- Upstream Processing
- Bioreactors
- Large-scale Bioreactors
- Single-use Bioreactors
- Consumables
- Bioreactors
- Downstream Processing
- Chromatography Systems
- Chromatography Resins
- Filtration
- Filtration Systems
- Filtration Consumables & Accessories
End-user
- Pharmaceutical and Biotechnology Companies
- Research Laboratories
- Other End-users
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
